Description: Elanco Animal Health Incorporated, an animal health company, develops, manufactures, and markets products for companion and food animals in the United States and internationally. It offers companion animal disease prevention products, such as parasiticide products that protect pets from worms, fleas, and ticks; companion animal therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications; vaccines, nutritional enzymes, and animal-only antibiotics; and food animal products used in ruminant and swine production. The company caters to veterinarians and food producers of countries in North America, South America, Asia-Pacific, Europe, the Middle East, and Africa. Elanco Animal Health Incorporated was founded in 1954 and is based in Greenfield, Indiana. Elanco Animal Health Incorporated operates as a subsidiary of Eli Lilly and Company.
Home Page: www.elanco.com
ELAN Technical Analysis
2500 Innovation Way
Greenfield,
IN
46140
United States
Phone:
877 352 6261
Officers
Name | Title |
---|---|
Mr. Jeffrey N. Simmons | Pres, CEO & Director |
Mr. Todd S. Young | Exec. VP of Corp. Governance and Strategy & CFO |
Mr. Ramiro Martin Cabral | Exec. VP & Pres of Elanco International |
Mr. James M. Meer | Sr. VP & Chief Accounting Officer |
Mr. Chris Keeley | Sr. VP & Chief Information Officer |
Mr. David S. Kinard | Exec. VP of HR Corp. Affairs & Admin. |
Ms. Marcela A. Kirberger | Exec. VP, Gen. Counsel & Corp. Sec. |
Mr. David Alan Urbanek | Exec. VP of Manufacturing & Quality |
Mr. Shawn McKee | Sr. VP of U.S. Companion Animal |
Mr. Larbi Van Lier | Sr. VP of Asia |
Exchange: NYSE
Country: US
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Pharmaceuticals |
GIC Sub-Industry: | Pharmaceuticals |
Forward PE: | 10.2354 |
---|---|
Trailing PE: | 0 |
Price-to-Book MRQ: | 0.8999 |
Price-to-Sales TTM: | 1.2755 |
IPO Date: | 2018-09-20 |
Fiscal Year End: | December |
Full Time Employees: | 9000 |